Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013, Article ID 752903, 4 pages
http://dx.doi.org/10.1155/2013/752903
Research Article

A Cost-Benefit and Accurate Method for Assessing Microalbuminuria: Single versus Frequent Urine Analysis

1Faculty of Medicine, Elam University of Medical Sciences, Elam, Iran
2Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, P.O. Box 81465-1148, Isfahan, Iran
3Hypertension Research Centre, Isfahan, Iran

Received 16 August 2013; Revised 6 October 2013; Accepted 7 October 2013

Academic Editor: Kazushi Tsuda

Copyright © 2013 Roholla Hemmati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Honeycutt, J. Segel, X. Zhuo, T. Hoerger, K. Imai, and D. Williams, “Medical Costs of CKD in the Medicare Population,” Journal of the American Society of Nephrology, 2013. View at Publisher · View at Google Scholar
  2. R. Vargas and K. Norris, “Kidney disease progression and screening cost-effectiveness among African Americans.journal of the american society Of nephrology,” vol. 23, no. 12, pp. 1915–1916, 2012. View at Publisher · View at Google Scholar
  3. H. Wu, J. Huang, Y. Peng et al., “Microalbuminuria screening for detecting chronic kidney disease in the general population: a systematic review,” Renal Failure, vol. 35, no. 5, pp. 607–614, 2013. View at Publisher · View at Google Scholar
  4. C. Kovesdy, E. Lott, J. L. Lu et al., “Outcomes associated with microalbuminuria: effect modification by chronic kidney disease,” Journal of the American College of Cardiology, vol. 61, no. 15, pp. 1626–1633, 2013. View at Publisher · View at Google Scholar
  5. S. Selvarajah, C. S. Uiterwaal, J. Haniff, Y. van der Graaf, F. L. Visseren, and M. L. Bots, “Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus,” European Journal of Clinical Investigation, vol. 43, no. 2, pp. 198–207, 2013. View at Publisher · View at Google Scholar
  6. F. Jarraya, R. Lakhdar, K. Kammoun et al., “Microalbuminuria: a useful marker of cardiovascular disease,” Iranian Journal of Kidney Diseases, vol. 7, no. 3, pp. 178–186, 2013. View at Google Scholar
  7. K. Yamamoto, Y. Komatsu, H. Yamamoto et al., “Establishment of a method to detect microalbuminuria by measuring the total urinary protein-to-creatinine ratio in diabetic patients,” The Tohoku Journal of Experimental Medicine, vol. 225, no. 3, pp. 195–202, 2011. View at Google Scholar · View at Scopus
  8. T. J. Hoerger, J. S. Wittenborn, X. Zhuo et al., “Cost effectiveness of screening for microalbuminuria among African Americans,” Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2035–2041, 2012. View at Publisher · View at Google Scholar
  9. T. J. Hoerger, J. S. Wittenborn, X. Zhuo et al., “Cost effectiveness of screening for microalbuminuria among African Americans,” Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2035–2041, 2012. View at Publisher · View at Google Scholar
  10. M. Gharipour, A. Khosravi, M. Sadeghi, H. Roohafza, M. Hashemi, and N. Sarrafzadegan, “Socioeconomic characteristics and controlled hypertension: evidence from Isfahan Healthy Heart Program,” ARYA Atheroscler, vol. 9, no. 1, pp. 77–81, 2013 Jan. View at Google Scholar
  11. H. Shemirani, A. Khosravi, R. Hemmati, and M. Gharipou, “Body mass index or microalbuminuria, which one is more important for the prediction and prevention of diastolic dysfunction in non-diabetic hypertensive patients?” International Journal of Preventive Medicine, vol. 3, no. 3, pp. 211–220, 2012. View at Google Scholar · View at Scopus
  12. S. L. White, K. R. Polkinghorne, R. C. Atkins, and S. J. Chadban, “Comparison of the Prevalence and Mortality Risk of CKD in Australia Using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR Estimating Equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study,” American Journal of Kidney Diseases, vol. 55, no. 4, pp. 660–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Kessler, G. Keusch, T. D. Szucs et al., “Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland,” Swiss Medical Weekly, vol. 142, Article ID w13508, 2012. View at Publisher · View at Google Scholar
  14. G. Lum, “How effective are screening tests for microalbuminuria in random urine specimens?” Annals of Clinical & Laboratory Science, vol. 30, no. 4, pp. 406–411, 2000. View at Google Scholar
  15. B. P. Tabaei, A. S. Al-Kassab, L. L. Ilag, C. M. Zawacki, and W. H. Herman, “Does microalbuminuria predict diabetic nephropathy?” Diabetes Care, vol. 24, no. 9, pp. 1560–1566, 2001. View at Publisher · View at Google Scholar